Loading ...

Stock Quote pars

pars Stock Price Today

pars Price History

pars Stock Price History

pars History

Last Price pars

Close Price pars

Day Change pars

After Hours Quote pars

Open Price pars

Day Range pars

Year Range pars

Projected Yield pars

Market Cap pars

Stock Volume pars

Average Volume pars

Forward Price pars

PE for pars

PB for pars

PS for pars

PCF for pars

price earnings ratio pars

price to book ratio pars

price to sales ratio pars

price to cash flow ratio pars

Stock Quote Pharmos Corp

Pharmos Corp Stock Price today

Pharmos Corp Price history

Pharmos Corp Stock Price history

Pharmos Corp history

Last Price Pharmos Corp

Close Price Pharmos Corp

Day Change Pharmos Corp

After Hours Quote for Pharmos Corp

Open Price Pharmos Corp

Day Range Pharmos Corp

Year Range Pharmos Corp

Projected Yield Pharmos Corp

Market Cap Pharmos Corp

Stock Volume Pharmos Corp

Average Volume Pharmos Corp

Forward Price Pharmos Corp

pe Pharmos Corp

pb Pharmos Corp

ps Pharmos Corp

pcf Pharmos Corp

price earnings ratio Pharmos Corp

price to book ratio Pharmos Corp

price to sales ratio Pharmos Corp

price to cash flow ratio Pharmos Corp

What Does This Company Do?
Pharmos Corp is a pharmaceutical Company that discovers and develops new novel therapeutic drugs to treat a range of indicators including pain, inflammatory, auto-immune and select CNS disorders.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Slow Growth
Employees
2
Stock Style

Key Stats  PARS More...

Key Stats PARS

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

Sponsor Center

News  pars - Pharmos Corp More...

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  pars - Pharmos Corp More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports pars - Pharmos CorpMore...

Click above to view more mutual fund data and stats for pars - Pharmos Corp.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Wall St. Recommendations  pars - Pharmos Corp More...

Wall Street Analyst Recommendation PARS

Stock Price Quote: pars Pharmos Corp - XOTC - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: pharm - Pharming Group  |  Next: pl-f - Phatra Leasing PLC